Limited effectiveness of radioiodine therapy for residual cervical lymph node metastases in radioiodine-naïve papillary thyroid cancer - Top-Institutions - MDSpire

Limited effectiveness of radioiodine therapy for residual cervical lymph node metastases in radioiodine-naïve papillary thyroid cancer

  • By

  • Seyfettin Ilgan

  • M.Özdeş Emer

  • Ferit Taneri

  • Erdinç Aygenç

  • Serdar Özbaş

  • Murat Akın

  • Erkan Öztürk

  • Banu Bilezikçi

  • Seza A. Gulec

  • July 6, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Endocrinology

  • #2

    First Hospital of Jilin University
    First Hospital of Jilin University

    Changchun, Jilin

    Key Differentiators

    • Endocrinology

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Endocrinology

Original Source(s)

Limited effectiveness of radioiodine therapy for residual cervical lymph node metastases in radioiodine-naïve papillary thyroid cancer

  • by Seyfettin Ilgan, M.Özdeş Emer, Ferit Taneri, Erdinç Aygenç, Serdar Özbaş, Murat Akın, Erkan Öztürk, Banu Bilezikçi, Seza A. Gulec

  • July 6, 2026

Related Content

Incidence and predictors of spontaneous thyroid-stimulating hormone normalization after lobectomy for low-risk papillary thyroid microcarcinoma: evidence from contemporary clinical practice

Metastatic malignant melanoma presenting as bilateral acute mastitis in a lactating woman: a case report and literature review

Cytokine delivery and targeting strategies in pet dogs with cancer: a comparative immuno-oncology approach